研发管线加速推进 彰显诺诚健华速度

证券市场红周刊
18 Aug 2022

8月2日晚,证监会发布公告称,按法定程序同意诺诚健华医药有限公司(简称“诺诚健华”)在科创板首次公开发行股票注册,开启“A+H”征程。资本市场一路广受认可的同时,原因就在于公司进展不断推进,创新潜能持续释放。今年受大环境影响,生物医药行业面临较大挑战,但仍有一些优秀的创新药企保持良好发展,比如诺诚健华。尤其过去几个月,诺诚健华好消息不断,在血液瘤、实体瘤和自身免疫性疾病领域都取得了不俗的进展。血液...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10